Clinical perspectives of emerging pathogens in bleeding disorders.

@article{Ludlam2006ClinicalPO,
  title={Clinical perspectives of emerging pathogens in bleeding disorders.},
  author={Christopher A. Ludlam and William G. Powderly and Samuel A. Bozzette and Michael R. Diamond and Marion A Koerper and Roshni Kulkarni and Bruce Ritchie and Jamie Ellen Siegel and Peter Simmonds and Samuel L. Stanley and Michael L. Tapper and Mario von Depka},
  journal={Lancet},
  year={2006},
  volume={367 9506},
  pages={252-61}
}
As a result of immunological and nucleic-acid screening of plasma donations for transfusion-transmissible viruses, and the incorporation of viral reduction processes during plasma fractionation, coagulation-factor concentrates (CFC) are now judged safe in terms of many known infectious agents, including hepatitis B and C viruses, HIV, and human T-cell… CONTINUE READING